Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Henk Boot

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
The Lancet. Oncology|April 14, 2018
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trialAnnemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, et al.
BMC Cancer|September 12, 2018
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancerAstrid E Slagter, Edwin P M Jansen, Hanneke W M van Laarhoven, et al.
Gastroenterology|March 9, 2010
One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndromeHans F A Vasen, Mohamed Abdirahman, Richard Brohet, et al.
BMC Cancer|April 27, 2019
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)Koen P Rovers, Checca Bakkers, Geert A A M Simkens, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
The Lancet. Oncology|April 14, 2018
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trialAnnemieke Cats, Edwin P M Jansen, Nicole C T van Grieken, et al.
BMC Cancer|September 12, 2018
CRITICS-II: a multicentre randomised phase II trial of neo-adjuvant chemotherapy followed by surgery versus neo-adjuvant chemotherapy and subsequent chemoradiotherapy followed by surgery versus neo-adjuvant chemoradiotherapy followed by surgery in resectable gastric cancerAstrid E Slagter, Edwin P M Jansen, Hanneke W M van Laarhoven, et al.
Gastroenterology|March 9, 2010
One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndromeHans F A Vasen, Mohamed Abdirahman, Richard Brohet, et al.
BMC Cancer|April 27, 2019
Perioperative systemic therapy and cytoreductive surgery with HIPEC versus upfront cytoreductive surgery with HIPEC alone for isolated resectable colorectal peritoneal metastases: protocol of a multicentre, open-label, parallel-group, phase II-III, randomised, superiority study (CAIRO6)Koen P Rovers, Checca Bakkers, Geert A A M Simkens, et al.
Pageof 6